Molecular Diagnostics
Acute COVID-19 Infections Are Characterized by Elevated Blood Levels of IL-26
Increased systemic IL-26 was found to be associated with markers of hyperinflammation and tissue damage in patients with acute COVID-19, suggesting that it may be a potential target for diagnosis, monitoring, and therapy in this disease. More...22 Nov 2022
New Tool Assesses Cost of ctDNA Testing
Circulating tumor DNA (ctDNA) is a promising new biomarker with multiple potential applications in cancer care. Estimating total cost of ctDNA testing is necessary for reimbursement and implementation, but challenging because of variations in workflow. More...22 Nov 2022
Multiplex Vaginal Panel Identifies Three Distinct Conditions in One Hour
A new multiplexed PCR test detects DNA from organisms associated with three distinct conditions – bacterial vaginosis, vulvovaginal candidiasis, and trichomoniasis – from a single sample, aiding in more accurate diagnosis and antibiotic treatment regimens. More...22 Nov 2022
Novel Assay Enables Simultaneous Detection of SMA and SCID in Newborns
PerkinElmer, Inc. (Waltham, MA, USA) has received US FDA authorization for the marketing of its EONIS SCID-SMA assay kit for in vitro diagnostic (IVD) use by certified laboratories for the simultaneous detection of SMA and SCID in newborns. More...22 Nov 2022
Simple Blood Test Could More Than Double Liver Cancer Detection Rate in High-Risk Population
A new study has shown that a test which is easy to perform with a routine blood sample and relatively low cost could more than double the number of liver cancer cases detected in a high-risk population compared to today's standard of care – a mix of ultrasound imaging and protein tests that few patients receive. More...22 Nov 2022
First-Ever Saliva-Based Concussion Test to Be Available in 2023
Currently, there are no biological tests to diagnose mild traumatic brain injury (mTBI) or concussion. Now, new research has revealed that biomarkers found in saliva may distinguish mTBI and parallel symptom recovery. More...21 Nov 2022
In Other News
Non-Invasive Saliva Test Predicts Future Risk for Alzheimer's
A Urine Test for Detection and Management of Cystic Fibrosis
Gene Signature Identifies Patients with Long-term Lyme Disease
Direct Real-Time PCR Protocol Detects Monkeypox Virus
Handheld Diagnostic Lab Offers POC Solution for Future Pandemics
Three-Protein Signature Blood Test Can Detect Undiagnosed Prediabetes
Novel Variant of Phosphorylated Tau Helps Fine Tune Early Diagnosis of Alzheimer’s Disease
POC Molecular Diagnostics Analyzer for Infectious Diseases Provides On-The-Spot Results
Rapid Test for G6PD Deficiency Runs on Toaster-Sized Instrument and Delivers Results in 15 Minutes at POC
New Urine Test Could Detect Childhood Kidney Disease Earlier than Current Assays
Breakthrough Diagnostic Technology Enables Quantitative Five-Minute Tests
World’s First Rapid Saliva-Based Pregnancy Test Set for Multi-Country Launch
Ultra-Fast Real-Time PCR Platform Could Revolutionize POC Molecular Diagnostics
Personalizing Whole Genome Sequencing Doubles Diagnosis of Rare Diseases
New Blood Test to Help Physicians Prevent Major Cardiovascular Events in Women with Lupus
Accurate Genetic Assay Identifies Human Neutrophil Antigen 2 Deficiency
Levels of the MicroRNA MiR-145 Predict Likelihood of Breast Cancer Recurrence
Nose Swabs May Distinguish Babies with RSV Needing Longer Intensive Care
New Immunoassay Specifically Measures Heart Attack-linked Blood Troponin Levels
A Procedure for Early Diagnosis of Pancreatic Cancer
Pathogen Analyzer Combines Advantages of Antigen and PCR Testing
Fast, Open and Digitalized PCR Platform Produces Results in 15 Minutes
Novel Phage- and CRISPR-Based Approaches to Enable Diagnosis of Sepsis in Blood Samples
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.